Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1987-2-3
|
pubmed:abstractText |
The suggestion that beta blockers can reduce mortality is not in dispute, nor is the undoubted clinical value of this important group of drugs. What must however be questioned is whether these beneficial effects can be, or need be, explained by 'infarct size limitation'.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0195-668X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
925-30
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
1986
|
pubmed:articleTitle |
Can beta blockers limit myocardial infarct size?
|
pubmed:publicationType |
Journal Article,
Review
|